Necrotic Skin Ulcers Following Apomorphine Subcutaneous Infusion Dose Escalation in Parkinson's Disease [0.03%]
帕金森病患者皮下输注阿扑吗啡剂量增加后出现坏死性皮肤溃疡
Viktoriya Shkatova,João Nuno Soares,José Carlos Cardoso et al.
Viktoriya Shkatova et al.
Safety and Efficacy of Focused Ultrasound Thalamotomy in Elderly Patients: A Single-Center Cohort Study [0.03%]
聚焦超声丘脑毁损治疗老年人特发性震颤的安全性和有效性：单中心队列研究
Vincenzo Daniele Boccia,Gabriele Bellini,Alon Mogilner et al.
Vincenzo Daniele Boccia et al.
Background: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is an established treatment for medication-refractory tremor with limited evidence in patients aged >80 years. ...
Peripheral Neuropathy during Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson's Disease: A Case Series [0.03%]
帕金森病患者皮下注射福斯左旋多巴/福斯卡比多的外周神经病变：个案系列研究
Lucie Vial-Daragon,Louis Poncet-Megemont,Philippe Derost et al.
Lucie Vial-Daragon et al.
Background: Peripheral neuropathy has been described in Parkinson's disease (PD) patients receiving continuous levodopa delivery. Whether subcutaneous foslevodopa/foscarbidopa (fLD/fCD) infusion carries a similar risk rem...
Case Reports
Movement disorders clinical practice. 2026 Apr 6. DOI:10.1002/mdc3.70629 2026
Phenotypic Clues in Infantile-Onset Parkinsonism-Dystonia-2: A Treatable Neurotransmitter Disorder [0.03%]
幼年发病的帕金森病-肌张力障碍-2型的表型线索：一种可治疗的神经递质疾病
Sangeetha Yoganathan,Haya S AlFaris,Lindsey Vogt et al.
Sangeetha Yoganathan et al.
Altitude-Related Midbrain Syndrome after Ventriculo-Peritoneal Shunt for Racemose Neurocysticercosis [0.03%]
racemose神经囊尾蚴病脑室-腹腔分流术后高海拔相关中脑综合征
Timothy D McWilliams,Betsy S Hanampa-Colquehuanca,Isabel Camargo-Salazar et al.
Timothy D McWilliams et al.
Next-Gen Olfactometry System for Olfactory Testing in Parkinson's Disease and High-Risk Individuals [0.03%]
下一代嗅觉测量系统在帕金森病及高危人群中的应用
Taiki Fukushima,Keita Hiraga,Daigo Tamakoshi et al.
Taiki Fukushima et al.
Background: Olfactory impairment is a key prodromal symptom of Parkinson's disease (PD), yet conventional Japanese olfactory tests require controlled rooms and time-consuming manual procedures, restricting large-scale use...
FXTAS and the Spectrum of FMR1 Premutation-Associated Phenotypes in Latin America: A Scoping Review [0.03%]
拉丁美洲FXTAS和FMR1突变相关表型谱系的范围：系统评价
Amy Schmidmajer,Salomón Páez-García,Santiago Martínez et al.
Amy Schmidmajer et al.
Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by FMR1 premutation expansions (55-200 CGG repeats). Although well described in populations of predominantl...
Bogdana Petko,Bastiaan R Bloem,Stewart A Factor
Bogdana Petko
Asymmetric Upper Limb Dysfunction Demonstrated at the Bedside: A Phenomenology Video [0.03%]
床边演示的不对称上肢功能障碍：现象学视频
Gero Lueg,Martin Fruth,Nina Rosa Neuendorff et al.
Gero Lueg et al.
Long-Term Benefit of GPi-DBS in Two Siblings with BCL11B-Related Dystonia: An Uncommon but Potentially Treatable Condition [0.03%]
BCL11B相关性 dystonia 两兄弟的 DBS(GPi)长期疗效观察：一种罕见但可能被治疗的疾病状态
Veronika Magocova,Tatiana Svorenova,Vladimir Han et al.
Veronika Magocova et al.
Case Reports
Movement disorders clinical practice. 2026 Apr 2. DOI:10.1002/mdc3.70611 2026